Consumer medicine information

APX-Quetiapine XR

Quetiapine

BRAND INFORMATION

Brand name

APX-Quetiapine XR

Active ingredient

Quetiapine

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using APX-Quetiapine XR.

What is in this leaflet

This leaflet answers some of the common questions people ask about APX-QUETIAPINE XR. It does not contain all the available information.

It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor will have weighed the risks of you taking it against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine. You may need to read it again.

What APX-QUETIAPINE XR is used for

APX-QUETIAPINE XR helps to correct chemical imbalances in the brain. It is used to treat conditions such as:

  • Bipolar disorder, an illness of in which there are sustained mood swings either up (mania) or down (depression). During mania, patients experience episodes of overactivity, elation or irritability. During depression, patients may feel depressed or guilty, lack energy, lose their appetite and have trouble sleeping.
  • Recurrent major depressive disorder, an illness where depression is longer lasting and/ or more severe than the "low moods" everyone has from time to time due to the stress of everyday life. It is thought to be caused by a chemical imbalance in parts of the brain. This imbalance affects your whole body and can cause emotional and physical symptoms such as feeling low in spirit, loss of interest in activities, being unable to enjoy life, poor appetite or overeating, disturbed sleep, often waking up early, loss of sex drive, lack of energy and feeling guilty over nothing.
  • Generalised anxiety disorder, where patients have excessive anxiety and worry.
  • Schizophrenia, an illness with disturbances in thinking, feelings and behaviour.

APX-QUETIAPINE XR belongs to a group of medicines called antipsychotics.

Ask your doctor if you have any questions about why APX-QUETIAPINE XR has been prescribed for you. Your doctor may have prescribed this medicine for another reason.

This medicine is only available with a doctor's prescription.

You may find it helpful to tell a friend or relative that you are suffering from these symptoms, and ask them to read this leaflet. You might ask them to tell you if they your symptoms are getting worse, or if they are worried about any other changes in your behaviour.

APX-QUETIAPINE XR is not addictive.

Before you take it

When you must not take it

Do not take APX-QUETIAPINE XR if you have an allergy to:

  • quetiapine, the active ingredient in APX-QUETIAPINE XR
  • any of the other ingredients listed at the end of this leaflet.

Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin or you may feel faint.

APX-QUETIAPINE XR is not recommended for use in children. There is not enough information on its effects in children.

APX-QUETIAPINE XR, as with other anti-psychotic medicines, is recommended for use with caution in the elderly and is not approved for treatment of dementia and behavioural disturbances. In clinical studies with this group of medicines for the treatment of dementia and behavioural disturbances in the elderly, have suggested an increased risk of cardiovascular adverse events including stroke, and increased mortality risk for elderly patients has been reported.

Do not take it after the use by (expiry) date printed on the pack. Do not take it if the packaging is torn or shows signs of tampering. If it has expired or is damaged, return it to your pharmacist for disposal.

If you are not sure whether you should start taking APX-QUETIAPINE XR talk to your doctor or pharmacist.

Before you start to take it

Tell your doctor if you have any allergies to:

  • any other medicines
  • any other substances such as foods, dyes or preservatives

Tell your doctor or pharmacist if you have, or have had, any medical conditions, especially the following:

  • heart or blood vessel problems or a family history of heart or blood vessel problems including low blood pressure, stroke, problems with your circulation or any condition that affects blood flow to the brain, problems with the way your heart beats or a history of heart attack
  • liver problems
  • diabetes or a family history of diabetes. Patients with diabetes or who have a higher chance of diabetes should have their blood sugar checked before and during treatment with QUETIAPINE XR GPPL.
  • epilepsy (seizures or fits)
  • dementia or related behavioural disorders (especially in elderly patients)
  • low white blood cell count
  • sleep apnoea – a condition where you stop breathing for short periods during your normal nightly sleep
  • urinary retention (a condition where you can’t completely empty your bladder)
  • an enlarged prostate
  • a blockage in your intestines
  • increased pressure inside your eyes or glaucoma
  • history of alcohol or drug abuse

Tell your doctor or mental health professional if you have any mental/mood changes or suicidal thoughts. Depression and other mental illnesses can increase the risk of suicide. It is important to discuss all the risks of treating depression and mental illness as well as the risks of not treating it. You should discuss all treatment choices with your doctor, not just the use of antidepressants.

Patients (and caregivers of patients) need to monitor for any worsening of their condition and/or the emergence of thoughts of suicide or suicidal behaviour or thoughts of harming themselves and to seek medical advice immediately if these symptoms present.

Do not take APX-QUETIAPINE XR if you are pregnant or breastfeeding unless your doctor says so. Ask your doctor about the risks and benefits involved. It is not known if it is safe for you to take it while you are pregnant. However, if you need to take it during your pregnancy, the doctor will discuss the risks and benefits of taking it with you.

It is recommended that you do not breastfeed while taking it, as it may pass into breast milk.

Before your doctor starts you on APX-QUETIAPINE XR your doctor may want to take some tests (eg blood tests, blood pressure, weight or height measurements). These tests may help to prevent side effects.

Tell your doctor if you are lactose intolerant. APX-QUETIAPINE XR tablets contain lactose.

Taking other medicines

Tell your doctor or pharmacist if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop.

Some medicines and APX-QUETIAPINE XR may interfere with each other, these include:

  • phenytoin or carbamazepine - medicines for epilepsy
  • medicines for high blood pressure (including diuretics or fluid tablets) or heart conditions
  • lorazepam - a medicine used to help you sleep
  • medicines used to treat anxiety, depression, mood swings, attention deficit hyperactivity disorder (ADHD) or other mood disorders
  • medicines for fungal infections such as ketoconazole
  • some antibiotics such as rifampicin and erythromycin
  • thioridazine - an antipsychotic medicine
  • medicines used to treat Parkinson's disease
  • stimulants such as amphetamines
  • glucocorticoids - medicines used to treat inflammation
  • medicines for Human Immunodeficiency Virus (HIV)
  • medicines that have anticholinergic (muscarinic) effects

These medicines may be affected by APX-QUETIAPINE XR, or may affect how well it works. You may need different amounts of your medicine or you may need to take different medicines. Your doctor will advise you.

Your doctor and pharmacist have more information about medicines to be careful with or avoid while taking APX-QUETIAPINE XR.

If you have not told your doctor about any of these things, tell them before you take any APX-QUETIAPINE XR.

How to take it

Follow all directions given to you by your doctor or pharmacist carefully. They may differ from the information contained in this leaflet.

If you do not understand the instructions on the pack ask your doctor or pharmacist for help.

How to take it

Swallow your APX-QUETIAPINE XR tablets whole with a full glass of water. Do not split, chew or crush the tablets. If you split, chew or crush the tablets they will not work properly.

How much to take

Your doctor will tell you how many tablets you will need to take each day and how long you need to take it. This depends on your condition and whether or not you are taking any other medicines.

APX-QUETIAPINE XR is usually started as a low dose that will be increased by your doctor. Your doctor will recommend a dose especially for you. This will depend on various factors including your age, condition being treated, other medical conditions (eg. liver problems), other medicines you are taking and how you may react to APX-QUETIAPINE XR. Your doctor will monitor your condition and may change your dose depending on how you respond to it. Your doctor will use the lowest dose for the least amount of time to keep you well.

Your doctor may have switched your treatment from Quetiapine immediate release tablets to APX-QUETIAPINE XR tablets. Your doctor will generally prescribe you a once daily dose of APX-QUETIAPINE XR, which is equivalent to your total daily dose of Quetiapine immediate release tablets. Your doctor will tell you how many tablets you will need to take each day.

When to take it

APX-QUETIAPINE XR should be taken once a day, at approximately the same time each day. Taking your tablets at the same time each day will have the best effect. It will also help you remember when to take the tablets.

It should be taken without food.

How long to take it

Continue taking the tablets for as long as your doctor tells you. APX-QUETIAPINE XR helps control your condition, but does not cure it. Therefore you must take it every day. Do not stop taking it unless your doctor tells you to - even if you feel better.

If you forget to take it

If it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to. Otherwise, take it as soon as you remember, and then go back to taking your medicine as you would normally.

Do not take a double dose to make up for the dose that you missed.

If you are not sure what to do, ask your doctor or pharmacist.

If you have trouble remembering when to take your medicine, ask your pharmacist for some hints.

If you take too much (overdose)

Immediately telephone your doctor or the Poisons Information Centre (13 11 26) for advice, or go to Accident and Emergency at your nearest hospital if you think that you or anyone else may have taken too much APX-QUETIAPINE XR. Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.

If you take too many APX-QUETIAPINE XR tablets you may feel drowsy, sleepy, dizzy or have fast heart beats.

While you are taking it

Things you must do

Tell any other doctors, dentists, and pharmacists who are treating you that you are taking it.

If you are about to be started on any new medicines, tell your doctor, dentist or pharmacist that you are taking it.

Tell your doctor or mental health professional immediately, or go to the nearest hospital, if you have any of the following suicidal thoughts or other mental/mood changes:

  • thoughts or talk of death or suicide
  • thoughts or talk of self-harm or harm to others
  • any recent attempts of self-harm
  • increase in aggressive behaviour, irritability or agitation
  • worsening of depression

Occasionally, the symptoms of depression may include thoughts of suicide or self-harm. These symptoms may continue or get worse during the early stages of treatment until the effect of the medicine becomes apparent. All mentions of suicide or violence must be taken seriously.

If you plan to have surgery that needs a general anaesthetic, tell your doctor or dentist that you are taking it.

If you become pregnant while taking it, tell your doctor immediately.

If you need to have any medical tests (including urine drug screening) while you are taking it, tell your doctor. It may affect the results of some tests.

Be sure to keep all of your doctor's appointments so that your progress can be checked. Your doctor will check your progress and may want to take some tests (eg. blood tests, blood pressure, weight or height measurements) from time to time. These tests may help to prevent side effects.

Things you must not do

Do not stop taking it, or change the dosage, even if you are feeling better, without checking with your doctor. If you stop taking it suddenly, your condition may worsen or your chance of getting an unwanted side effect may increase. To prevent this, your doctor may gradually reduce the amount of APX-QUETIAPINE XR you take each day before stopping completely.

Do not take it to treat any other complaints unless your doctor tells you to.

Do not give this medicine to anyone else, even if their symptoms seem similar or they have the same condition as you.

Do not take any medicines that cause drowsiness while you are taking it, unless recommended by your doctor.

Things to be careful of

Be careful driving or operating machinery until you know how APX-QUETIAPINE XR affects you. It can make some people dizzy or sleepy. Make sure you know how you react to it before you drive a car, operate machinery or do anything else that could be dangerous if you are dizzy or sleepy.

If it makes you feel light-headed, dizzy or faint, be careful when getting up from a sitting or lying position. Standing up slowly, especially when you get up from bed or chairs, will help your body get used to the change in position and blood pressure. If this problem continues or gets worse, talk to your doctor.

Be careful when drinking alcohol while you are taking it. Combining APX-QUETIAPINE XR and alcohol can make you more sleepy or dizzy. Your doctor may suggest you avoid alcohol while you are being treated with it.

Avoid getting over-heated or dehydrated - do not overexercise, in hot weather stay inside in a cool place, stay out of the sun, do not wear too much or heavy clothing, drink plenty of water. Keep warm in cool weather. APX-QUETIAPINE XR may affect the way your body reacts to temperature changes.

Avoid drinking large quantities of grapefruit juice. This medicine may be affected by grapefruit juice. Talk to your doctor or pharmacist if you have any concerns.

Talk to your doctor or pharmacist about these things if you think they may bother you.

Side effects

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking it.

All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects. Some side effects may be related to the dose of APX-QUETIAPINE XR or may be more likely to occur during long term treatment. Therefore, it is important that you tell your doctor as soon as possible if you notice anything that is making you feel unwell, even if you think the problems are not connected with this medicine. Your doctor may then decide to adjust your dose or use a different medicine.

Ask your doctor or pharmacist to answer any questions you may have.

Tell your doctor if you notice any of the following and they worry you:

  • feeling sleepy
  • weight gain, increased appetite
  • dry mouth
  • upset stomach, constipation, indigestion, vomiting (mainly in elderly or children)
  • feeling weak
  • swelling of the hands, ankles or feet
  • runny or stuffy nose (particularly in children)
  • blurred vision
  • abnormal dreams, nightmares
  • Irritability
  • confusion
  • shortness of breath, difficulty in breathing and/or tightness in the chest
  • fast or irregular heartbeats (palpitations)
  • muscle pain or swelling or weakness

These side effects are usually mild. Some of these side effects may go away after a while.

Tell your doctor as soon as possible if you notice the following:

  • difficulty swallowing
  • falling, feeling dizzy or faint on standing up
  • flat and red skin lesions or substantial hemorrhages under the skin (purpura)
  • difficulty in speaking
  • rapid heart beat
  • symptoms of high sugar levels in the blood (including passing large amounts of urine, excessive thirst, increase in appetite with a loss of weight, feeling tired, drowsy, weak, depressed, irritable and generally unwell)
  • breast enlargement, unusual secretion of breast milk

These are serious side effects. You may need medical attention.

If any of the following happen, tell your doctor immediately or go to Accident and Emergency at your nearest hospital:

  • abnormal muscle movements, including difficulty starting muscle movements, shaking, restlessness or muscle stiffness without pain.
  • worm-like movements of the tongue or other uncontrolled movements of the tongue, mouth, cheeks or jaw which may progress to the arms and legs
  • a sudden increase in body temperature, with sweating, or a fast heart beat
  • bleeding or bruising more easily than normal
  • very marked drowsiness
  • reduced consciousness
  • fits (seizures)
  • long-lasting and painful erections
  • fainting (particularly in children)
  • widespread skin rash that may include blistering or peeling of the skin, often accompanied by flu like symptoms, fever, swelling of the face and/or swollen lymph nodes (painful, warm, or red lump under your skin - often under your chin, on your neck, groin, armpit or behind your ear). These symptoms may also be associated with changes in your blood (eg white blood cell increase, as sometimes seen in allergic reactions) or liver function. These are some of the symptoms of potentially lifethreatening conditions called Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS).
  • severe allergic reaction (may include severe difficulty in breathing, shock, swelling of the face, lips, tongue or other parts of the body, skin rash, hayfever, or you may feel faint)
  • signs of frequent infections such as fever, chills, sore throat or mouth ulcers
  • severe upper stomach pain, often with nausea and vomiting (particularly in patients with other risk factors such as gallstones, alcohol consumption and/or increased levels of certain fats within the blood). These are symptoms of pancreatitis.
  • Combination of fever, very marked drowsiness, muscle stiffness, marked increase in blood pressure or heartbeats and reduced consciousness (a disorder called “neuroleptic malignant syndrome”

These are very serious side effects. Stop using APX-QUETIAPINE XR if you develop these symptoms. You may need urgent medical attention or hospitalisation.

Occasionally, APX-QUETIAPINE XR may be associated with changes in your liver function or blood (eg blood fat levels such as cholesterol or triglyceride, blood sugar levels, blood pressure, thyroid hormone levels, white blood cells). These can only be found when your doctor does tests from time to time to check your progress.

Other side effects not listed here may occur in some patients. Tell your doctor or pharmacist if you notice anything that is making you feel unwell.

Do not be alarmed by this list of possible side effects. You may not experience any of them.

After taking it

Storage

Keep your tablets in the blister pack until it is time to take them. If you take the tablets out of the blister pack they will not keep well.

Keep it in a cool dry place where the temperature stays below 25°C.

Do not store it or any other medicine in the bathroom or near a sink. Do not leave it in the car or on a window sill. Heat and dampness can destroy some medicines.

Keep it where children cannot reach it. A locked cupboard at least one-and- a-half metres above the ground is a good place to store medicines.

Disposal

If your doctor tells you to stop taking it or the tablets have passed their expiry date, ask your pharmacist what to do with any that are left over.

Product description

What APX-QUETIAPINE XR looks like

Quetiapine (as fumarate) modified release tablets are available in blister packs of 60 tablets. Tablet descriptions of the different strengths are detailed below.

APX-QUETIAPINE XR 50 mg

  • Light pink to pink, capsule shaped, biconvex, coated tablet, plain on both sides.

APX-QUETIAPINE XR 150 mg

  • White to off-white, round, biconvex, coated tablet, plain on both sides.

APX-QUETIAPINE XR 200 mg

  • Yellow, capsule shaped, biconvex, coated tablet, plain on both sides.

APX-QUETIAPINE XR 300 mg

  • Pale yellow, capsule shaped, biconvex, coated tablet, plain on both sides.

APX-QUETIAPINE XR 400 mg

  • White to off-white, capsule shaped, biconvex, coated tablet, plain on both sides.

Ingredients

Each APX-QUETIAPINE XR tablet contains quetiapine fumarate as the active ingredient equivalent to quetiapine 50 mg, 150 mg, 200 mg, 300 mg or 400 mg.

Other ingredients include:

  • Lactose monohydrate
  • Microcrystalline cellulose
  • Magnesium oxide, light
  • Carrageenan
  • Povidone
  • Magnesium stearate
  • Macrogol 400
  • Titanium dioxide (E171)
  • Iron oxide red (50 mg only)
  • Iron oxide yellow (50 mg, 200 mg and 300 mg)

This medicine contains sugars as lactose.

APX-QUETIAPINE XR tablets do not contain gluten or sucrose.

Supplier

Arrotex Pharmaceuticals Pty Ltd
15-17 Chapel St
Cremorne VIC 3121

This leaflet was prepared in March 2022.

Australian Registration Numbers:

50 mg - AUST R 199887
150 mg - AUST R 199885
200 mg - AUST R 199876
300 mg - AUST R 199867
400 mg - AUST R 199869

Published by MIMS April 2022

BRAND INFORMATION

Brand name

APX-Quetiapine XR

Active ingredient

Quetiapine

Schedule

S4

 

1 Name of Medicine

Quetiapine fumarate.

2 Qualitative and Quantitative Composition

APX-Quetiapine XR modified release tablets come in five strengths and contain quetiapine fumarate equivalent to 50 mg, 150 mg, 200 mg, 300 mg and 400 mg of quetiapine free base.
Excipients with known effect. Contains sugars as lactose.
The tablets are gluten free.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

APX-Quetiapine XR 50 mg. Quetiapine (as fumarate) 50 mg modified release tablet; Light pink to pink, capsule shaped, biconvex, coated tablet, plain on both sides.
APX-Quetiapine XR 150 mg. Quetiapine (as fumarate) 150 mg modified release tablet; White to off-white, round, biconvex, coated tablet, plain on both sides.
APX-Quetiapine XR 200 mg. Quetiapine (as fumarate) 200 mg modified release tablet; Yellow, capsule shaped, biconvex, coated tablet, plain on both sides.
APX-Quetiapine XR 300 mg. Quetiapine (as fumarate) 300 mg modified release tablet; Pale yellow, capsule shaped, biconvex, coated tablet, plain on both sides.
APX-Quetiapine XR 400 mg. Quetiapine (as fumarate) 400 mg modified release tablet; White to off-white, capsule shaped, biconvex, coated tablet, plain on both sides.

4 Clinical Particulars

4.9 Overdose

In clinical trials, experience with quetiapine in overdosage is limited. Survival has been reported in acute overdoses of up to 30 grams of quetiapine. Most patients who overdosed reported no adverse events or recovered fully from the reported events. Death has been reported in a clinical trial following an overdose of 13.6 grams of quetiapine alone. In post-marketing experience, there have been very rare reports of overdose of quetiapine alone resulting in death or coma.
In post-marketing experience there were cases reported of QT prolongation with overdose.
Patients with pre-existing severe cardiovascular disease may be at an increased risk of the effects of overdose (see Section 4.4 Special Warnings and Precautions for Use, Concomitant cardiovascular illness).
In general, reported signs and symptoms were those resulting from an exaggeration of the drug's known pharmacological effects, i.e. drowsiness and sedation, tachycardia, hypotension and anticholinergic effects.
Management of overdose. There is no specific antidote to quetiapine. In cases of severe signs, the possibility of multiple drug involvement should be considered, and intensive care procedures are recommended, including establishing and maintaining a patent airway, ensuring adequate oxygenation and ventilation, and monitoring and support of the cardiovascular system. Whilst the prevention of absorption in overdose has not been investigated, administration of activated charcoal together with a laxative should be considered.
In cases of quetiapine overdose, refractory hypotension should be treated with appropriate measures such as intravenous fluids and/or sympathomimetic agents (adrenaline and dopamine should be avoided, since β-stimulation may worsen hypotension in the setting of quetiapine-induced α-blockade).
Close medical supervision and monitoring should be continued until the patient recovers.
Quetiapine overdose may lead to gastric bezoar formation and an appropriate diagnostic imaging is recommended to further guide patient management. Routine gastric lavage may not be effective in the removal of the bezoar due to the gum like sticky consistency of the mass.
Endoscopic pharmacobezoar removal has been performed successfully in many cases.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. Genetic toxicity studies with quetiapine show that it is not a mutagen or clastogen. Quetiapine showed no evidence of genotoxicity in a series of assays for gene mutation (bacteria and Chinese hamster ovary cells) and chromosomal damage (human lymphocytes and the in vivo micronucleus test).
Carcinogenicity. In the rat study (20, 75 and 250 mg/kg/day) the incidence of mammary adenocarcinomas was increased at all doses in female rats, consequential to prolonged hyperprolactinaemia. The incidence of carcinoma of the adrenal cortex was increased in male rats at the highest dose.
In male rat (250 mg/kg/day) and mouse (250 and 750 mg/kg/day), there was an increased incidence of thyroid follicular cell benign adenomas, consistent with known rodent-specific mechanisms resulting from enhanced hepatic thyroxine clearance.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSQUETIA.gif Chemical Name: Bis[2-(2-[4-(dibenzo[b,f][1,4]-thiazepin-11-yl) piperazin-1-yl] ethoxy) ethanol] fumarate.
Quetiapine fumarate has a molecular formula of C46H54N6O8S2 and a molecular weight of 883.
Quetiapine fumarate is a weak acid (pKa 3.3, 6.8) which exhibits moderate pH dependent solubility (94.3 mg/mL to 2.37 mg/mL at pH values from 1 to 9) and lipophilicity characteristics (Log P) which vary with pH (0.45 in water, 1.37 at pH 5, 2.65 at pH 7 and 2.59 at pH 9). Quetiapine fumarate has an aqueous solubility of 3.29 mg/mL at 25°C.
CAS number. 111974-72-2.

7 Medicine Schedule (Poisons Standard)

Prescription Only Medicine - S4.

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/APXQUEST.gif